{
    "clinical_study": {
        "@rank": "127713", 
        "acronym": "ENVOL", 
        "arm_group": {
            "arm_group_label": "Biomarkers, total blood volume", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether the Biomarkers (pro adrenomedullin (MR\n      proADM), pro arginin vasopressin (CT proAVP), pro atrial natriuretic peptid (MR proANP), Pro\n      Endothelin) changes at Day 2, Day 5 and Day 7 of ICU admission are correlated with\n      Intravascular volume assessed by Cr 51 on red blood cells (Day 2 and Day 7) and by I 125 on\n      albumine Day 7. The correlation of these Biomarkers are also evaluted with other markers\n      such as erythropoietin and catecholamines. 80 ICU patients are included."
        }, 
        "brief_title": "Biomarkers Correlation With Volemia", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Cerebral Hemorrhage", 
            "Head Injury", 
            "Non Traumatic Post Surgery", 
            "Poly Trauma Patients Without Heart Failure", 
            "Renal Insufficiency"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Craniocerebral Trauma", 
                "Heart Failure", 
                "Hemorrhage", 
                "Multiple Trauma", 
                "Renal Insufficiency", 
                "Wounds and Injuries", 
                "Cerebral Hemorrhage"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  20 Cerebral Hemorrhage\n\n          -  20 Head Injury\n\n          -  20 post surgery non traumatic non neuro\n\n          -  20 Polytrauma patients\n\n        Exclusion Criteria:\n\n          -  Heart failure NYHA III or IV\n\n          -  Renal insufficiency creatinin clearance < 30 ml/mn\n\n          -  age < 18 Y\n\n          -  Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01858675", 
            "org_study_id": "2011-A01310-41"
        }, 
        "intervention": {
            "arm_group_label": "Biomarkers, total blood volume", 
            "intervention_name": "Biomarkers, red blood cells and plasma assessment", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "ProADM", 
            "ProANP", 
            "proendothelin", 
            "proAVP", 
            "Cr 51", 
            "Volemia", 
            "fluid management", 
            "ICU patients", 
            "poly trauma patients"
        ], 
        "lastchanged_date": "May 16, 2013", 
        "location": {
            "contact": {
                "email": "bernard.vigue@bct.aphp.fr", 
                "last_name": "Bernard Vigu\u00e9, Dr MD PHD", 
                "phone": "+33 1 45 21 34 45"
            }, 
            "facility": {
                "address": {
                    "city": "Le Kr\u00e9milin Bic\u00eatre", 
                    "country": "France", 
                    "state": "Ile de France", 
                    "zip": "94 275"
                }, 
                "name": "H\u00f4pital Bic\u00eatre"
            }, 
            "investigator": [
                {
                    "last_name": "Pierre- Etienne Leblanc, DR MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Bernard Vigu\u00e9, Dr MD PHD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Predictive Value of Biomarkers on Volemia, Extra and Intra Vascular Varation and Hydroelectrolytic Disorders in Different ICU Patients", 
        "overall_contact": {
            "email": "bernard.vigue@bct.aphp.fr", 
            "last_name": "Bernard Vigu\u00e9, Dr MD PHD", 
            "phone": "+33 1 45 21 34 45"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Correlation with total blood volume(assessed by Cr 51) and biomarkers(Mr proADM, Mr proANP, CT proAVP and proendothelin)changes", 
            "measure": "Predictive value of biomarkers changes in Volemia variation", 
            "safety_issue": "No", 
            "time_frame": "at Day 2, Day 5 and Day 7 of ICU admission"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01858675"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Correlation with efficient volemia and Biomarkers ( Mr proADM, Mr proANP, CT proAVP and proendothelin)changes.", 
                "measure": "Predictive value of biomarkers changes with efficient volemia, fluid managements and other Markers such erythropoietin", 
                "safety_issue": "No", 
                "time_frame": "at Day 2, Day 5 and Day 7 of ICU admission"
            }, 
            {
                "description": "Correlation of Biomarkers changes with APACHE II and SOFA score and Mortality at Day 2, Day 5 and Day 7 of their ICU admission and at ICU discharge.", 
                "measure": "Predictive value of Biomarkers with APACHE II and SOFA score and Prognosis at ICU discharge", 
                "safety_issue": "No", 
                "time_frame": "at Day 2 , Day 5 and Day 7 of ICU admission and at discharge"
            }
        ], 
        "source": "ThermoFisher Scientific Brahms Biomarkers France", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "ThermoFisher Scientific Brahms Biomarkers France", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}